Drug Discovery World
DECEMBER 14, 2023
The new hub will become a part of the already thriving life sciences sector in the Glasgow area, most of which is centred around the university, the Cancer Research UK Scotland Institute and the BioCity cluster, making Glasgow and its surrounds one of the most important regions for drug discovery and development in the UK.
The Pharma Data
JANUARY 5, 2021
” This press release contains forward-looking statements about the future development of the Sartorius Stedim Biotech Group. Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 5, 2021
6, 2021 /PRNewswire/ — The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. . Proposed transaction builds on both companies’ strategic R&D partnership.
The Pharma Data
DECEMBER 23, 2020
INOVIO is also assessing nonclinical efficacy of INO-4800 in several animal challenge models with Public Health England (PHE) and Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia.
XTalks
FEBRUARY 11, 2021
The RNA is transcribed from DNA in 40-liter vessels containing enzymes and chemicals over the course of three to four days. The vaccine is then ready to be filled into vials using a high-speed vial filling machine that dispenses six doses into each container. BioNTech is also launching a factory upgrade in Puurs, Belgium.
The Pharma Data
NOVEMBER 15, 2020
She chairs the board of directors of Sellas Life Sciences, a publicly traded biotechnology company, chairs its nominations & governance committee, and is a member of its audit, compensation and finance committees. and international leadership positions, including Staff Vice President and Associate General Counsel.
The Pharma Data
JANUARY 27, 2021
As a bioscience accelerator at the leading-edge of the life science industry, XPhyto targets growth through commercialization of its product pipeline and focused investment in impact driven innovation with the potential for meaningful value creation. . VANCOUVER, BC / ACCESSWIRE / January 28, 2021 / XPhyto Therapeutics Corp.
Expert insights. Personalized for you.
75 
Let's personalize your content